Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Biomarker for Transthyretin-Related Familial Amyloidotic Polyneuropathy - An International, Multicenter, Epidemiological Protocol

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02713880
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:19.444217+00:00
Published At
2023-02-10T00:00:00+00:00
Record Updated At
2023-02-10
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Transthyretin Amyloidosis", "Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy", "Transthyretin Amyloid Cardiopathy"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-02-10"
protocolSection.identificationModule.nctId
"NCT02713880"
protocolSection.identificationModule.officialTitle
"Biomarker for Transthyretin-Related Familial Amyloidotic Polyneuropathy - An International, Multicenter, Epidemiological Protocol"
protocolSection.statusModule.overallStatus
"WITHDRAWN"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Transthyretin Amyloidosis (protocolSection.conditionsModule.conditions)
  • Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy (protocolSection.conditionsModule.conditions)
  • Transthyretin Amyloid Cardiopathy (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.